XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,040,952 | +1357.4% | 1,084,337 | +1542.5% | 0.02% | +1500.0% |
Q2 2023 | $2,541,616 | -34.2% | 66,016 | -38.9% | 0.00% | -50.0% |
Q1 2023 | $3,863,960 | +72.4% | 107,962 | +90.0% | 0.00% | +100.0% |
Q4 2022 | $2,241,004 | -56.5% | 56,835 | -60.2% | 0.00% | -50.0% |
Q3 2022 | $5,152,000 | -60.6% | 142,726 | -66.8% | 0.00% | -66.7% |
Q2 2022 | $13,079,000 | +13.6% | 429,960 | +14.2% | 0.01% | +50.0% |
Q1 2022 | $11,514,000 | +25.3% | 376,651 | +28.1% | 0.00% | +33.3% |
Q4 2021 | $9,188,000 | +128.6% | 294,098 | +11.8% | 0.00% | +50.0% |
Q3 2021 | $4,020,000 | +983.6% | 263,103 | +1221.6% | 0.00% | – |
Q2 2021 | $371,000 | – | 19,908 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |